Sanofi Consumer Healthcare Intrinsic Value
SANOFICONR Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹2292.40 | ₹1833.92 - ₹2750.88 | -48.2% | EPS: ₹104.20, Sector P/E: 22x |
| Book Value Method | asset | ₹885.28 | ₹796.75 - ₹973.81 | -80.0% | Book Value/Share: ₹118.70, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹1327.92 | ₹1195.13 - ₹1460.71 | -70.0% | Revenue/Share: ₹392.61, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹1770.56 | ₹1593.50 - ₹1947.62 | -60.0% | EBITDA: ₹334.00Cr, EV/EBITDA: 10x |
| PEG Ratio Method | growth | ₹1667.20 | ₹1500.48 - ₹1833.92 | -62.3% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹1680.23 | ₹1512.21 - ₹1848.25 | -62.0% | Revenue Growth: 15.0%, Adj P/E: 16.1x |
| ROE Based Valuation | profitability | ₹2213.20 | ₹1991.88 - ₹2434.52 | -50.0% | ROE: 87.9%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹1327.92 | ₹1195.13 - ₹1460.71 | -70.0% | EPS: ₹104.20, BVPS: ₹118.70 |
Want to compare with current market value? Check SANOFICONR share price latest .
Valuation Comparison Chart
SANOFICONR Intrinsic Value Analysis
What is the intrinsic value of SANOFICONR?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Sanofi Consumer Healthcare (SANOFICONR) is ₹1680.23 (median value). With the current market price of ₹4426.40, this represents a -62.0% variance from our estimated fair value.
The valuation range spans from ₹885.28 to ₹2292.40, indicating ₹885.28 - ₹2292.40.
Is SANOFICONR undervalued or overvalued?
Based on our multi-method analysis, Sanofi Consumer Healthcare (SANOFICONR) appears to be trading above calculated value by approximately 62.0%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 14.00 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 87.9% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 35.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 2.10x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
Related Pages for Sanofi Consumer Healthcare
Additional stock information and data for SANOFICONR
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2024 | ₹439 Cr | ₹439 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |